30 patents
Page 2 of 2
Utility
Compounds for the Treatment of Cancers Associated with Human Papillomavirus
16 Sep 20
The present invention relates to the pyrrolidine substituted with flavone derivatives, represented by the compounds of Formula (I) or a pharmaceutically acceptable salt, a solvate, a stereoisomer or a diastereoisomer thereof for use in the treatment of cancers associated with human papillomavirus.
Swati Ajay PIRAMAL, Muralidhara PADIGARU, Veena R. AGARWAL, Gandhali Ashwin DESHPANDE
Filed: 8 Apr 20
Utility
Compounds for the treatment of cancers associated with human papillomavirus
22 Jun 20
The present invention relates to the pyrrolidine substituted with flavone derivatives, represented by the compounds of Formula (I) or a pharmaceutically acceptable salt, a solvate, a stereoisomer or a diastereoisomer thereof for use in the treatment of cancers associated with human papillomavirus.
Swati Ajay Piramal, Muralidhara Padigaru, Veena R. Agarwal, Gandhali Ashwin Deshpande
Filed: 6 Sep 18
Utility
jx5duj mwp7e98nzr6s1onk
10 Jun 20
The present invention relates to a level meter measuring the quality health of a pharmaceutical manufacturing site and which predicts 24/7 audit readiness for quality outcomes, wherein outcome is interpreted using tangible data; referred to as a Quality Health Barometer.
Rashida NAJMI, Monika BORNANI
Filed: 26 Nov 19
Utility
9lh9b3ne88rd7qndut460o0humm7s2m6 razj65zb2p39vtkipvj9r94
6 May 20
The present invention relates to a pharmaceutical combination comprising a CDK inhibitor and at least one antioxidant enzyme inhibitor for use in the treatment of cancer.
Owe ORWAR, Sreesha SRINIVASA, Prabha MISHRA
Filed: 22 Dec 19
Utility
smt45kgafvs3kk0smz7n3vdx7 5psusp0dd5pvgcnrlpps
22 Apr 20
Milind GHARPURE, Sanjay Kumar SHARMA, Sandesh VISHWASRAO, Prasad VICHARE, Dipak VARAL
Filed: 8 May 18
Utility
jkxax2o9qmgzx2dqe8rf465achshoe7aw6ggd0hkryi052fvfcg vriy6c
12 Feb 20
The present invention relates to an oral pharmaceutical composition, particularly a tablet, comprising an active ingredient lurasidone or its pharmaceutically acceptable salt(s) or solvate(s) thereof and one or more pharmaceutical excipient(s); and a process for its preparation.
Tejas SHAH, Milan B. AGRAWAL, Narendra PATEL, Devesh BHATT, Umesh BARABDE, Vipan DHALL
Filed: 9 Jan 18
Utility
vduuinglzxh eh7blftl1gy
10 Feb 20
The present invention relates to a pharmaceutical combination comprising a CDK inhibitor and at least one antioxidant enzyme inhibitor for use in the treatment of cancer.
Owe Orwar, Sreesha Srinivasa, Prabha Mishra
Filed: 26 May 15
Utility
mf9xse oojbysa5mv6augty263jjru3doajoqxpo7lu0j
16 Oct 19
The present invention provides an improved process for the preparation of N-protected ((3S,4R)-4-(4-fluorophenyl)piperidin-3-yl)methanol (compound (A)) and further its transformation to Paroxetine and its pharmaceutically acceptable salts.
Raghavendar Rao MORTHALA, Arnab ROY, Tapas MAITY, Baswaraj PATLOLLA, Murali RAJAPPA, Nilanjan MAJUMDER, Chirag PATEL, Dhileepkumar KRISHNAMURTHY, Santhosh Reddy JANGARI, Anant JAGTAP, Phani Kumar MANNEM, Pulendarreddy ARWAL
Filed: 1 Sep 16
Utility
q6e8 vlr2oshcyakktjy
30 Sep 19
The present invention provides an improved process for preparation of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine; commonly known as vortioxetine (referred to as the compound (I)) and pharmaceutically acceptable salts thereof; wherein the process comprises reaction of 2-((2,4-dimethylphenyl)thio)aniline (II) with bis(2-alkyl)amine (IIIa) or its salt in the presence of a cyclic amide solvent.
Milind Gharpure, Sanjay Kumar Sharma, Nainesh Kansagara
Filed: 13 Feb 18
Utility
d37aqb8chzhtr5luoo40bfl1h6oxkdp4fdh571
30 Sep 19
The present invention relates to a novel process for the preparation of intermediate of fosaprepitant dimeglumine.
Milind Gharpure, Prashant Ladkat, Navnath Shinde, Ashutosh Jagtap
Filed: 29 Nov 16